Project Grant R01MH137613

Award Date 5/1/25
Completion Date 4/30/30
Dollars Obligated $795K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a $673,803 research study on the relationship between parent-child neurobehavioral synchrony and early ADHD symptom trajectories in preschool-aged children. The 5-year study, running from December 2024 to November 2029, will be conducted by the University of Pittsburgh to examine how parent-child focused attention and neural synchrony influence...
This $857,216 federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants will be used by Boston Children's Hospital to conduct a longitudinal study examining the neurodevelopmental trajectories and social determinants leading to early symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and disruptive behaviors in children. The study will leverage an existing large, diverse cohort of low-resourced infants seen in an...
This federal Project Grant award of $746,183 was issued by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The award is intended to fund a prospective, longitudinal study by the University of South Carolina to evaluate preterm infants' autonomic nervous system (ANS) dysfunction as a potential etiological mechanism for the development of autism spectrum disorder (ASD) and other neurodevelopmental impairments (NDI). The key objectives...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to characterize early signs of neurobehavioral dysregulation in infants at increased risk for behavioral disorders. Specifically, the $197,660 award to Duke University will leverage integrative data analysis techniques to identify modifiable mechanisms that increase risk for behavior dysregulation in toddlers (Aim 1). The project will also...
This federal Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $367,708 in funding to the University of Southern California (USC) for a research project titled "Neural Substrates of Autism and ADHD: Reward Circuitry Connectivity and Individual Differences". The key objectives of this 5-year project are to investigate the functional connectivity patterns of reward regions in Autism Spectrum Disorder (ASD) and...
This $392,500 federal Project Grant award was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to the University of California, Irvine. The grant supports a 5-year research project from January 1, 2025 to December 31, 2029 to study the developmental origins of mental illness, with a focus on understanding how early life adversity impacts the structure and function of the hypothalamus and its contribution to maladaptive...
This $148,423 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a research project to characterize the neurodevelopmental and physiological mechanisms of sensorimotor integration in autism spectrum disorder (ASD), including individuals with intellectual disability (ID). The study aims to clarify the sensory feedback and brain mechanisms associated with deficient control of fine and gross motor...
This federal Project Grant award of $809,312 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to characterize circadian function and its implications for clinical and cognitive functioning in children with Attention-Deficit/Hyperactivity Disorder (ADHD). The study, conducted by Duke University and its subcontractor RTI International, will use gold-standard dim light melatonin onset (DLMO) assessment as well as innovative...
The National Institute of Mental Health (NIMH) awarded a $357,876 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Duke University to develop and utilize electrophysiological and behavioral biomarkers for endophenotyping, stratification, and measuring response to intervention to improve social engagement in autism. The 4-year grant, with a start date of September 1, 2024, aims to prepare the principal investigator, Dr. Alexandra Bey, for an independent research...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $2,535,618.00 to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to advance the understanding of genomic mechanisms for primary Attention-Deficit/Hyperactivity Disorder (ADHD) in families. The key products and services to be delivered through this 5-year award include: 1) Developing the largest family-based...

This federal Project Grant award, totaling $794,931 and awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program, will support a research project titled "EARLY DYADIC SYNCHRONY AND MIDDLE CHILDHOOD OUTCOMES AMONG INFANTS AT GENETIC RISK FOR ADHD OR AUTISM" at the University of California, Davis.

The project aims to investigate the influence of early parent-infant synchrony on the development of ADHD and autism spectrum disorder (ASD) symptoms, as well as broader social and self-regulatory outcomes, in middle childhood. The research will leverage three prospective longitudinal cohorts of infants (N=326) with varying familial risk for ADHD and ASD, building on the principal investigator's prior NIMH-funded studies. The project will use novel automated methods to analyze previously collected videos of naturalistic parent-infant interactions, examining how early dyadic synchrony impacts outcomes at ages 6-10 years, and exploring moderators and mediators of these associations, including genetic risk factors.

The award, which commenced on May 1, 2025, will fund this comprehensive, longitudinal investigation through the ultimate completion date of April 30, 2030.

Generated 5/13/25, 2:07 AM